Бенатекс® tablets vaginal

General characteristics. Structure:

Active agent: Benzalkoniya chloride (in terms of 100% substance) – 20 mg; Excipients Starch corn prezhelatinizirovanny, stearic acid, cellulose microcrystallic (for the medical purposes), adipic acid, a macrogoal (polyethyleneglycol) – before receiving a tablet weighing 550 mg.

Pharmacological properties:

Contraceptive local (spermicidal) means, renders also antiseptic, antifungal, anti-protozoan, action; inactivates the Herpes simplex virus. Shows bactericidal activity concerning stafilokokk, streptococci, gram-negative bacteria (intestinal and pyocyanic sticks, gonokokk, a protea, klebsiyella and others), anaerobic bacteria, mushrooms and pleseny. Affects strains of the bacteria steady against antibiotics and other chemotherapeutic medicines; suppresses a plazmokoagulaza and hyaluronidase of stafilokokk. Spermicidal action is caused by ability to damage membranes of spermatozoa (at the beginning of flagellums, then a head) that causes impossibility of fertilization by the damaged spermatozoon. The effect develops in 8-10 minutes after introduction of a vaginal tablet. Shows activity in the prevention of diseases, sexually transmitted (gonorrhea, clamidiosis, trichomoniasis). Also the hormonal cycle does not influence normal microflora of a vagina (including Doderlyayn's stick). The pharmacokinetics is Practically not soaked up at intravaginalny introduction, is removed a simple podmyvaniye water and with normal physiological allocations.

Indications to use:

Local contraception for women of reproductive age, including existence of contraindications to use of oral contraceptives or intrauterine contraception; puerperal period, lactation period; the period after abortion; premenopauzny period; need of incidental protection from pregnancy; the admission or delay in reception of constantly used oral contraceptives. Prevention of diseases, sexually transmitted.

Route of administration and doses:

Intravaginalno. Previously having exempted from planimetric packaging, the tablet is entered deeply into a vagina in a dorsal decubitus in 10 min. prior to sexual intercourse; action duration - 3 h. Single dose: 1 tablet is counted on 1 sexual intercourse. It is obligatory to enter a new vaginal tablet in case of repeated sexual intercourses. Frequency rate of use is limited to individual portability of active ingredient and frequency of sexual intercourses.

Features of use:

Increase in efficiency requires careful observance of a route of administration of drug. Use together with a vulval diaphragm or intrauterine contraception is possible. After a coitus intravaginalny use of hygienic means (syringing by soap water since soap destroys active substance of drug) in order to avoid loss of contraceptive effect is not recommended; the outside toilet of generative organs is possible.

Side effects:

Allergic reactions: itch, burning, contact dermatitis.

Interaction with other medicines:

Any medicine entered intravaginalno can reduce local spermicidal action (including soap and solutions, it containing).

Contraindications:

Hypersensitivity to drug components, a colpitis, an ulceration and irritation of a mucous membrane of a vagina and neck of uterus.

Overdose:

Due to the low system absorption the overdose is improbable. Now symptoms of overdose are not described.

Storage conditions:

List B. To store in the dry, protected from light place at a temperature not above 25 °C. To store in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

Tablets vaginal 20 mg. On 5, 6, 7, 10 or 12 tablets in a blister strip packaging from a film of the polyvinyl chloride and printing aluminum foil varnished. 1, 2 or 3 blister strip packagings together with the instruction on a medical use of drug in a pack from a cardboard.